Takaisin Tulosta

Vakavat mielenterveyden häiriöt: omahoidon tuki ja metabolisen riskin seuranta

Lisätietoa aiheesta
Käypä hoito -työryhmä Insuliininpuutosdiabetes


  1. Suvisaari J, Perälä J, Saarni SI ym. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci 2008;258:129-36 «PMID: 17990051»PubMed
  2. Young-Hyman D, de Groot M, Hill-Briggs F ym. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126-2140 «PMID: 27879358»PubMed
  3. Koro CE, Fedder DO, L'Italien GJ ym. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ 2002;325:243 «PMID: 12153919»PubMed
  4. Meyer JM, Nasrallah HA. Medical Illness and Schizophrenia 2nd ed. American Psychiatric Publishing 2009, Inc. Arlington, Virginia (VA).
  5. Smith R. The macrophage theory of depression. Med Hypothesis 1991;35: 4, 298-306.
  6. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008;19:10-6 «PMID: 18082417»PubMed
  7. Lieberman JA, Stroup TS, McEvoy JP ym. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23 «PMID: 16172203»PubMed
  8. Lustman PJ, Griffith LS, Clouse RE ym. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997;59:241-50 «PMID: 9178335»PubMed
  9. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010;71:1259-72 «PMID: 21062615»PubMed
  10. McIntyre RS, Konarski JZ, Misener VL ym. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005;17:83-93 «PMID: 16075661»PubMed
  11. Schulte PF, Bocxe JT, Doodeman HJ ym. Risk of New-Onset Diabetes After Long-Term Treatment With Clozapine in Comparison to Other Antipsychotics in Patients With Schizophrenia. J Clin Psychopharmacol 2016;36:115-9 «PMID: 26872114»PubMed